$DJI 0.13% NDX 0.46% SPX 0.26% VIX 1.57% News *
Wed, Sep 18 1:38am

GILD $66.17 0.29 (0.44%)
Gilead Sciences Inc

GILD Profile

Market Cap 84.99 Billion
GILD Description

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.


Visit Website

GILD Earnings

EPS 1.48 P/E Ratio 55.20
Previous Thu, May 2, 2019
Latest Tue, Jul 30, 2019 (50 days ago) -2.50%

GILD Dividend

Yield 3.45% / $2.28
Ex-Date Thu, Dec 13, 2018 (279 days ago)
Pay Date Fri, Dec 28, 2018
History 15 Payments (Quarterly)

GILD Charts

$60.47
1 Year
$79.61
Dec 24, 2018
Oct 3, 2018


Symbol Price Day Δ YTD Δ
GILD $66.17 0.44% 4.30%

Advertisers

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy